Informed Risk Assessment: Leveraging Preclinical Safety Intelligence to anticipate Clinical Adverse Events

Event date: 26.06.2024

Join Clarivate on June 26th at 4 pm CEST to explore “Informed Risk Assessment: Leveraging Preclinical Safety Intelligence to anticipate Clinical Adverse Events.” Discover how OFF-X’s tools mitigate risks in drug development, focusing on Semagacestat, BTK inhibitors, and 4-1BB activators. Enhance patient safety and streamline your development process with valuable insights ???

Agenda:
1.     Challenges the pharma industry continues to face today
2.     How the safety intelligence tool OFF-X can help de-risk drug development
3.     Drug – Semagacestat
4.     Target – BTK inhibitors
5.     Target- 4-1BB activators
6.     Summary
7.     Q&A

back